Compassion Center Urges DEA to Reschedule Cannabis to Schedule III During December 2, 2024, Hearing
Compassion Center urges the DEA to reschedule cannabis to Schedule III of the Controlled Substances Act during the December 2,...
Pharmaceutical
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),...
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company...
As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL
CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the...
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second...
GRI Bio to Present at the 2024 European Respiratory Congress
LA JOLLA, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
Next Generation Medical Writing Course: A 14-week, trainer-led, online, specially curated medical writing certificate course by Turacoz
DUBAI, UAE and RIYADH, Saudi Arabia and NEW DELHI, Sept. 4, 2024 /PRNewswire/ -- The global medical writing market is...
IRLAB is Granted Additional Patent for Drug Candidate Mesdopetam that Expands its Patent Protection
GOTHENBURG, SWEDEN / ACCESSWIRE / September 4, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 4, 2024 - IRLAB Therapeutics...
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today...
ProofPilot Bolsters Advisory Board with Appointment of Michelle Everill
NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for...
EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations
Support from the Brain Tumor Investment Fund, a subsidiary of the National Brain Tumor Society, and Sontag Innovation Fund Strengthens...
Health Union Launches First-of-Its-Kind People-based Data Engine
ILLUMINÉ™ Harnesses the Power of Community to Build Privacy-first, Persona-Based Media Solutions PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Health Union,...
Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health
The investment is a pivotal milestone allowing Segmed to further expand its medical imaging solutions for artificial intelligence development and...
IDBS is proud to announce the renewal of its ISO 9001 and ISO 27001 certificates
WOKING, England, Sept. 3, 2024 /PRNewswire/ -- IDBS, a provider of cloud software for BioPharma companies, is pleased to announce...
PhaseV to Present at Upcoming Healthcare, Pharma and Technology Events
New Research and Case Studies Demonstrate Effectiveness of Machine Learning-Based Platforms for Adaptive Clinical Trial Design and Analysis BOSTON, Sept....
IntegriChain Appoints Tim Murdoch as Chief Commercial Officer to Drive Continued Growth and Customer Value
PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry,...
Humonix Bio Announces Appointment of Thurein Htoo as Chairman of the Board of Directors and Welcomes Christie Markowitz as New Independent Board Director
ALBANY, NY / ACCESSWIRE / September 3, 2024 / Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased...
Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval...
Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
Avenue Therapeutics to Participate in Upcoming Investor Conferences
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...